Patents Assigned to CANADIAN BLLOOD SERVICES
  • Combination therapy of acellular pro-tolerogenic and pro-inflammatory preparations for modulating the immune system
    Patent number: 10561685
    Abstract: This disclosure relates to a cellular-based therapies for modulating the level of regulatory T cells (Treg) and/or the level of pro-inflammatory T cells (Th17/Th1). To provide these therapeutic effects, a combination comprising at least one a cellular pro-tolerogenic preparation and at least one a cellular pro-inflammatory preparation are administered sequentially.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: February 18, 2020
    Assignee: CANADIAN BLLOOD SERVICES
    Inventors: Mark D. Scott, Duncheng Wang, Wendy M. Toyofuku